Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.
ASSURE In the News
Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.